Adenovirus Expression Vector Kit (Dual Version) Ver.2
Reference
• Reference literature
Adenovirus Expression Vector Kit (Dual Version)
1) Graham,FL., Smiley,J., Russell,WC., and Nairn,R. (1977) J. Gen. Virol., 36, 59
2) Miyake,S., Makimura,M., Kanegae,Y., Harada,S., Takamori,K., Tokuda,C., and Saito,I. (1996) Proc. Natl. Acad. Sci. USA, 93, 1320
3) Berkner, K. L., and Sharp, P. A. (1983) Nucl. Acids Res., 11, 6003.
4) Kanegae,Y., Lee,G., Sato,Y., Tanaka,M., Nakai,M., T.Sasaki, T.Sugano, S. and Saito,I.(1995) Nucl. Acids Res., 23, 3816.
5) Ueno, T., Matsumura, H., Tanaka, K., Iwasaki, T., Ueno, M., Fujinaga, K., Asada, K. and Kato, I. (2000) Biochem. Biophys. Res. Commun., 273, 473.
6) Okuyama, T., Fujino, M., Li, X. K.., Funeshima, N., Kosuga, M., Saito, I.,Suzuki, S. and Yamada, M. (1998) Gene Therapy, 5, 1047.
7) Sudo, M., Okado, H.., Iino, M., Tsuzuki, K., Miwa, A., Kanagae, Y., Saito, I. and Ozawa, S. (1999) Mol. Brain Res., 65, 176.
8) Niwa, H., Yamamura, K., and Miyazaki, J. (1991) Gene, 108, 193.
9) Kanegae, Y., Makimura, M., and Saito, I. (1994) Jpn. J. Med. Sci. Biol., 47, 153
10) Lochmuller, H., Jani, A., Huard, J., Prescott, S., Simoneae, M., Massie, B., Karpati, G. and Acsadi, G. (1994) Human Gene Therapy, 5, 1485.
11) Hehir, K. M, Armentano, D., Cardoza L. M., Choquette T. L., Berthelette P. B., White G. A., Couture L. A., Everton M. B., Keegan J., Martin J. M., Pratt D. A., Smith A. E. and Wadsworth S. C. (1996) J. of Virol., 70, 8459.
12) Zhang, W. W., Koch, P. E., and Roth, J. A. (1995) BioTech., 18, 444.
13) Dion, L. D., Fang, J. and Garver Jr., R. I. (1996) J. of Virological Methods, 56, 99.
14) Saito, I., Oya, Y., Yamamoto, K., Yuasa, T. and Shimojo, H. (1995) J. of Viroloy, 54, 71
1) Graham,FL., Smiley,J., Russell,WC., and Nairn,R. (1977) J. Gen. Virol., 36, 59
2) Miyake,S., Makimura,M., Kanegae,Y., Harada,S., Takamori,K., Tokuda,C., and Saito,I. (1996) Proc. Natl. Acad. Sci. USA, 93, 1320
3) Berkner, K. L., and Sharp, P. A. (1983) Nucl. Acids Res., 11, 6003.
4) Kanegae,Y., Lee,G., Sato,Y., Tanaka,M., Nakai,M., T.Sasaki, T.Sugano, S. and Saito,I.(1995) Nucl. Acids Res., 23, 3816.
5) Ueno, T., Matsumura, H., Tanaka, K., Iwasaki, T., Ueno, M., Fujinaga, K., Asada, K. and Kato, I. (2000) Biochem. Biophys. Res. Commun., 273, 473.
6) Okuyama, T., Fujino, M., Li, X. K.., Funeshima, N., Kosuga, M., Saito, I.,Suzuki, S. and Yamada, M. (1998) Gene Therapy, 5, 1047.
7) Sudo, M., Okado, H.., Iino, M., Tsuzuki, K., Miwa, A., Kanagae, Y., Saito, I. and Ozawa, S. (1999) Mol. Brain Res., 65, 176.
8) Niwa, H., Yamamura, K., and Miyazaki, J. (1991) Gene, 108, 193.
9) Kanegae, Y., Makimura, M., and Saito, I. (1994) Jpn. J. Med. Sci. Biol., 47, 153
10) Lochmuller, H., Jani, A., Huard, J., Prescott, S., Simoneae, M., Massie, B., Karpati, G. and Acsadi, G. (1994) Human Gene Therapy, 5, 1485.
11) Hehir, K. M, Armentano, D., Cardoza L. M., Choquette T. L., Berthelette P. B., White G. A., Couture L. A., Everton M. B., Keegan J., Martin J. M., Pratt D. A., Smith A. E. and Wadsworth S. C. (1996) J. of Virol., 70, 8459.
12) Zhang, W. W., Koch, P. E., and Roth, J. A. (1995) BioTech., 18, 444.
13) Dion, L. D., Fang, J. and Garver Jr., R. I. (1996) J. of Virological Methods, 56, 99.
14) Saito, I., Oya, Y., Yamamoto, K., Yuasa, T. and Shimojo, H. (1995) J. of Viroloy, 54, 71
• Used Reference
Adenovirus Expression Vector Kit (Cat.#6170) Citations
in vivo- J Clin Invest. 2005; 115(3):718-27.
Taniguchi C M, et al.
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. - J Clin Invest. 2004; 114(2):224-31.
Satoh H, et al.
Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. - Invest Ophthalmol Vis Sci. 2004; 45(5):1289-96.
Akiyama H, et al.
Inhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel-Lindau tumor-suppressor gene in vivo. - Circulation. 2004; 109(9):1147-53.
Kawai J, et al.
Endogenous adrenomedullin protects against vascular response to injury in mice. - J Biol Chem. 2003; 278(43):41804-9.
Ono M, et al.
Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. - Am J Pathol. 2003; 162(4):1191-201.
Nochi H, et al.
Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules. - Circulation Research. 2003; 92(1):e12-9.
Tamamori-Adachi M, et al.
Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. - Hypertension. 2003; 41(2):302-7.
Yamasaki M, et al.
Adrenomedullin overexpression to inhibit cuff-induced arterial intimal formation. - Proc Natl Acad Sci U S A. 2001; 98(9):5175-80.
Nakanishi A, et al.
Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma.
in vitro
- J Immunol. 2006; 176(6):3461-9.
Iinuma H, et al.
Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma. - J Cell Biol. 2006; 172(4):589-604.
Hoshino M, et al.
Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and p73. - J Clin Invest. 2005; 115(1):138-45.
Hashimoto N, et al.
PKClambda regulates glucose-induced insulin secretion through modulation of gene expression in pancreatic beta cells. - J Biol Chem. 2005; 280(13):12867-75.
Mori T, et al.
Role of Kruppel-like Factor 15 (KLF15) in Transcriptional Regulation of Adipogenesis. - J Biol Chem. 2005; 280(17):17562-71.
Qiao B, et al.
Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling. - J. Immunol., 2005; 174: 4025-4033.
Katsuaki Sato, et al.
TRAIL-Transduced Dendritic Cells Protect Mice from Acute Graft-versus-Host Disease and Leukemia Relapse. - Mol Cell Biol. 2005; 25(5):1971-9.
Hata K, et al.
A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. - Diabetes. 2005; 54(2):462-71.
Herrero L, et al.
Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the beta-cell impairs glucose-induced insulin secretion.
Note
- All products are intended to be used for research purpose only. They are not to be used for drug or diagnostic purposes, nor are they intended for human use. They shall not to be used products as food, cosmetics, or utensils, etc
- Takara products may not be resold or transferred, modified for resale or transfer, or used to manufacture commercial products without written approval from TAKARA BIO INC.
- If you require licenses for other use, please call at +81 77 543 7247 or contact from our website at www.takara-bio.com
- Please confirm the content about the license or patent used in this document that relates to the Takara Bio product by clicking the license mark.
Moreover, please confirm the "Limited Use Label License" or "patent" concerning the product of another manufacturers or respective owners in their Web site/catalog etc.














